STIM: Neuronetics Company Sales Revenue

Neuronetics, Inc. (STIM) develops non-invasive magnetic stimulation systems to combat depression, offering a safe alternative to medication. Business growth relies on the sale of high-margin session cards that reduce costs. A consumables model utilizing digital keys generates additional profit. The company's total commercial revenue is clearly illustrated on this chart, where the 0.16 mark reflects the latest data.

Revenue and Sales Volume: Neuronetics (STIM) for 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for Neuronetics (STIM)

- current price and projected stock value:

Share Price Neuronetics, Inc|STIM - Consensus Target

- market capitalization information:

Market Value Neuronetics, Inc.|STIM - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share Neuronetics|STIM - Book Capitalization|Market-to-Book Ratio neurostar.com|STIM - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

STIM - Net Income|Expected Net Income Neuronetics, Inc.|STIM - P/E Multiple|Projected Price to Earnings Ratio neurostar.com|STIM - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple Neuronetics, Inc.|STIM - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Neuronetics|STIM - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months neurostar.com|STIM - Earnings per share growth in current year|Net earnings per share change forecast for next year Neuronetics, Inc.

- company sales and revenue statistics:

STIM - Company Revenue|Company Future Sales Volume Neuronetics, Inc|STIM - P/S Multiple|Market Cap to Future Revenue Ratio Neuronetics, Inc.

Summary company analysis:STIM Neuronetics, Inc

This metric captures net cash flow from operating activities, excluding the volatility of market expectations. It measures the business's actual ability to generate daily revenue, confirming its intrinsic financial stability. For Neuronetics, Inc. (STIM), this indicator reflects a high degree of physician confidence in NeuroStar systems. Stable demand for equipment converts into predictable cash flows. An analysis of the company's aggregated sales allows for an objective assessment of the fundamental business development trend.

Key competitors